术前栓塞改善非典型WHO 2级脑膜瘤局部控制并调控基因表达
该回顾性队列纳入1997至2021年319例WHO 2级非典型脑膜瘤患者,其中106例(33.2%)接受术前栓塞。生物信息学分析提示术前栓塞富集细胞分化和缺氧相关通路,抑制有丝分裂和细胞周期进展通路。
要点
- 术前栓塞未显著改变围手术期失血量或手术时间。
- 术前栓塞与更长无复发生存期独立相关,次全切除者获益更明显。
- 术前栓塞可能通过抑制细胞周期通路改善长期肿瘤学结局。
核心结论
- 术前栓塞可改善非典型WHO 2级脑膜瘤的局部控制并调控基因表达。
研究设计与样本
- 回顾性识别1997至2021年机构数据库中接受切除的WHO 2级脑膜瘤患者319例,其中106例(33.2%)接受术前栓塞。
- 采用单因素和多因素Cox比例风险模型及倾向匹配进行临床分析,并利用DNA甲基化谱、bulk RNA测序和靶向基因表达谱数据探索分子特征。
主要发现
- 术前栓塞与未栓塞患者相比围手术期结局(如失血量或手术时间)无显著变化。
- 生物信息学分析显示术前栓塞富集细胞分化和缺氧相关通路,抑制有丝分裂和细胞周期进展通路。
临床怎么用
- 对于非典型WHO 2级脑膜瘤,尤其是计划次全切除的患者,可考虑术前栓塞以改善局部控制。
- 术前栓塞未显著增加围手术期风险,但需结合患者具体情况个体化决策。
局限性
- 回顾性单中心研究,存在选择偏倚可能。
- 分子分析基于可用数据,样本量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Preoperative embolization is hypothesized to reduce blood loss and operative time for meningioma resection, but the impact of preoperative embolization on long-term oncological outcomes and molecular features of meningiomas is incompletely understood. Here, we investigate how preoperative embolization influences perioperative and long-term outcomes as well as molecular features of atypical WHO grade 2 meningiomas. METHODS: Patients who underwent resection of WHO grade 2 meningiomas from 1997 to 2021 were retrospectively identified from an institutional database. Univariate and multivariate Cox proportional hazards modeling and propensity matching were used for clinical analyses. Available DNA methylation profiling, bulk RNA sequencing, and targeted gene expression profiling data were used to elucidate how preoperative embolization influences the molecular architecture of atypical WHO grade 2 meningiomas. RESULTS: A total of 319 patients with atypical WHO grade 2 meningiomas were identified, of which 106 (33.2%) underwent preoperative embolization without significant changes in perioperative outcomes, such as blood loss or operative time, in comparison to patients who did not undergo preoperative embolization. In propensity matched multivariate analyses, preoperative embolization was independently associated with longer recurrence-free survival (RFS, HR 0.55, 95% CI 0.31-0.96, P = .037), particularly in patients with subtotal resection (median RFS 16.2 years vs 5.9 years, P = .045; HR 0.32, 95% CI 0.14-0.70, P = .005). Bioinformatic analyses demonstrated that preoperative embolization led to enrichment of pathways linked to cellular differentiation and hypoxia, and suppression of pathways implicated in mitosis and cell cycle progression, suggesting that improved long-term oncological outcomes may occur through inhibition of the cell cycle in atypical WHO grade 2 meningiomas. CONCLUSIONS: Preoperative embolization improves local control and modulates gene expression in atypical WHO grade 2 meningiomas, a subgroup of meningiomas that have intermediate clinical outcomes with standard interventions.
引用
- Haddad AF, Ramesh R, Zakimi N, et al. Preoperative embolization improves local control and modulates gene expression in atypical WHO grade 2 meningioma. Neuro Oncol. 2025. PMID: 40916651. doi:10.1093/neuonc/noaf203
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。